Tm Biosciences' Q2 Revenues Climb 55 Percent Though Loss Widens | GenomeWeb
NEW YORK (GenomeWeb News) – Tm Bioscience today reported that net losses for the second quarter increased despite a 55-percent surge in revenues.
 
The company reported $3 million in revenues for the quarter ended June 30, up from $2 million during the same quarter a year ago.
 
Product sales for the second quarterclimbed 80 percent to $2.9 million from $1.6 million in second quarter 2005, the company said. It added that sales of Tag-It CF70 reagents and increased demand from Genzyme drove the growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.